Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A meta-analysis of 14 studies has shown AI algorithms correctly diagnose diseases in medical imaging around 87% of the time while ruling out specific diseases with 93% accuracy.
Machine learning can read cardiac MRIs with the same accuracy as a physician, with much higher speed, according to a recent study published in Circulation: Cardiovascular Imaging and reported by Cardiovascular Business.
Deep-learning analysis of eye scans has proven superior to conventional analysis of the same images for the task of detecting and tracking vision diseases like glaucoma and age-related macular degeneration.
Researchers in Australia are about to begin testing, in humans, a brain-computer interface created to restore communication in people with severe paralysis.
The number of lung injury cases reported from around the country has risen to 530, according to the CDC’s latest update. The number of reported deaths has been upped to seven, as of September 19.
Auditory specialists placing Cochlear implants in hearing-impaired patients may position the devices better with an assist from AI than with conventional methods.
Portable ultrasound maker Fujifilm SonoSite has turned to the nonprofit Allen Institute for Artificial Intelligence’s AI2 Incubator for help harnessing AI’s image-interpretation potential.
Machine learning analysis of Raman hyperspectroscopy—a technology used to measure the intensity of scattered laser light—has shown strong potential as a screening tool for Alzheimer’s disease when applied to an easily obtainable lab specimen: saliva.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
